|Articles|November 15, 2002

Timolol hemihydrate offers brand-name efficacy as beta-blocker

Newark, NJ-Timolol hemihydrate (Betimol, Santen Inc.) is an excellent choice when a beta-blocker is indicated for IOP-lowering in patients with ocular hypertension or glaucoma, said Paul J. Lama, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME